Abstract
The authors recently demonstrated that the mitochondrial voltage-dependent anion channel 1 (VDAC1) is involved in the sensitivity of cancer cells to furanonaphthoquinone (FNQ). The aim of the present study was to investigate whether mitochondrial VDAC1 reduces quinone antitumor drugs. The VDAC1 purified by immunoprecipitation reduced FNQ in the presence of nicotinamide adenine dinucleotide (NADH) and produced H2O2. Blue native polyacrylamide gel electrophoresis demonstrated that the band that reduced FNQ NADH-dependently mainly included VDAC1. Because H2O2 generation in catalyzing FNQ with NADH caused mitochondrial damage, the cytotoxic activity of FNQ was induced by VDAC1. In the quinone antitumor drugs, menadione (VK3), adriamycin and mitomycin C, mitochondrial VDAC1 bioreductively activated VK3. These results demonstrate that mitochondrial VDAC1 is a pharmacologic target for the treatment of tumor.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bachur NR, Gordon SL, Gee MV, Kon H (1979) NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. Proc Natl Acad Sci USA 76, 954–7.
Baker MA, Lane DJ, Ly JD, De Pinto V, Lawen A (2004) VDAC1 is a transplasma membrane NADH-ferricyanide reductase. J Biol Chem 279, 4811–19.
Colombini M (1980) Structure and mode of action of a voltage dependent anion-selective channel (VDAC) located in the outer mitochondrial membrane. Ann N Y Acad Sci 341, 552–63.
Crompton M, Barksby E, Johnson N, Capano M (2002) Mitochondrial intermembrane junctional complexes and their involvement in cell death. Biochimie 84, 143–52.
Desmond JC, Kawabata H, Mueller-Tidow C et al. (2005) The synthetic furanonaphthoquinone induces growth arrest, apoptosis and differentiation in a variety of leukaemias and multiple myeloma cells. Br J Haematol 131, 520–29.
Gilloteaux J, Jamison JM, Arnold D, Taper HS, Summers JL (2001) Ultrastructural aspects of autoschizis: A new cancer cell death induced by the synergistic action of ascorbate/menadione on human bladder carcinoma cells. Ultrastruct Pathol 25, 183–92.
Goeptar AR, Groot EJ, Scheerens H, Commandeur JN, Vermeulen NP (1994) Cytotoxicity of mitomycin C and adriamycin in freshly isolated rat hepatocytes: The role of cytochrome P450. Cancer Res 54, 2411–28.
Harlow E, Lane D (1988) Antibodies: A Laboratory Manual. Cold Spring Harbor laboratory, New York.
Hatta T, Matsumoto A, Ono A et al. (2006) Quantitative analyses of leukemia inhibitory factor in the cerebrospinal fluid in mouse embryos. Neuroreport 17, 1863–6.
Hirai K-I, Koyama J, Pan J et al. (1999) Furanonaphthoquinone analogs possessing preferential antitumor activity compared to normal cells. Cancer Detect Prev 23, 539–50.
Hirai K-I, Shimada H, Pan J, Katoh S, Simamura E (1999) Mitochondrial NADH-quinone oxidoreductase (NQOm) produces reactive oxygen species in the chemical injury of rat liver mitochondria. Acta Histochem Cytochem 32, 239–42.
Hodnick WF, Sartorelli AC (1993) Reductive activation of mitomycin C by NADH: Cytochrome b 5 reductase. Cancer Res 53, 4907–12.
Ishigaki Y, Li X, Serin G, Maquat LE (2001) Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20. Cell 106, 607–17.
Iyanagi T, Yamazaki I (1970) One-electron-transfer reactions in biochemical systems. V. Difference in the mechanism of quinone reduction by the NADH dehydrogenase and the NAD(P)H dehydrogenase (DT-diaphorase). Biochim Biophys Acta 216, 282–94.
Iyer VN, Szybalski W (1964) Mitomycins and porfiromycin: Chemical mechanism of activation and cross-linking of DNA. Science 145, 55–8.
Jamison JM, Gilloteaux J, Venugopal M et al. (1996) Flow cytometric and ultrastructural aspects of the synergistic antitumor activity of vitamin C-vitamin K3 combinations against human prostatic carcinoma cells. Tissue Cell 28, 687–701.
Joseph P, Jaiswal AK (2000) A unique cytosolic activity related but distinct from NQO1 catalyses metabolic activation of mitomycin C. Br J Cancer 82, 1305–11.
Joseph P, Long DJ, Klein-Szanto AJ, Jaiswal AK (2000) Role of NAD(P)H: Quinone oxidoreductase 1 (DT diaphorase) in protection against quinone toxicity. Biochem Pharmacol 60, 207–14.
Keyes SR, Fracasso PM, Heimbrook DC, Rockwell S, Sligar SG, Sartorelli AC (1984) Role of NADPH: Cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1. Cancer Res 44, 5638–43.
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680–85.
Madesh M, Hajnoczky G (2001) VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release. J Cell Biol 155, 1003–15.
McEnery MW, Snowman AM, Trifiletti RR, Snyder SH (1992) Isolation of the mitochondrial benzodiazepine receptor: Association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc Natl Acad Sci USA 89, 3170–74.
Pan J, Hirai K-I, Simamura E, Koyama J, Shimada H, Kuwabara S (1997) Mitochondrial damage by a new antitumour agent furanonaphthoquinone derivative in human cervical cancer HeLa cells. J Electron Microsc (Tokyo) 46, 181–7.
Pan J, Koyama J, Matayoshi A, Hirai K-I (1999) Structural injury of osteosarcoma mitochondria by a novel antitumour agent, 2-methylfuranonaphthoquinone. J Electron Microsc (Tokyo) 48, 449–54.
Pan J, Simamura E, Koyama J, Shimada H, Hirai K-I (2000) Induced apoptosis and necrosis by 2-methylfuranonaphthoquinone in human cervical cancer HeLa cells. Cancer Detect Prev 24, 266–74.
Rostovtseva TK, Tan W, Colombini M (2005) On the role of VDAC in apoptosis: Fact and fiction. J Bioenerg Biomembr 37, 129–42.
Saotome K, Morita H, Umeda M (1989) Cytotoxicity test with simplified crystal violet staining method using microtitre plates and its application to injection drugs. Toxic Vitro 3, 317–21.
Schagger H, von Jagow G (1991) Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem 199, 223–31.
Shimada H, Hirai K-I, Simamura E, Pan J (1998) Mitochondrial NADH-quinone oxidoreductase of the outer membrane is responsible for paraquat cytotoxicity in rat livers. Arch Biochem Biophys 351, 75–81.
Siegel D, Beall H, Senekowitsch C et al. (1992) Bioreductive activation of mitomycin C by DT-diaphorase. Biochemistry 31, 7879–85.
Siegel D, Gibson NW, Preusch PC, Ross D (1990) Metabolism of mitomycin C by DT-diaphorase: Role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res 50, 7483–9.
Simamura E, Hirai K-I, Shimada H, Koyama J (2001) Apoptosis and epithelial phagocytosis in mitomycin C-treated human pulmonary adenocarcinoma A549 cells. Tissue Cell 33, 161–8.
Simamura E, Hirai K-I, Shimada H, Koyama J, Niwa Y, Shimizu S (2006) Furanonaphthoquinones cause apoptosis of cancer cells by inducing the production of reactive oxygen species by the mitochondrial voltage-dependent anion channel. Cancer Biol Ther 5, 1523–9.
Simamura E, Hirai K-I, Shimada H, Pan J, Koyama J (2003) Mitochondrial damage prior to apoptosis in furanonaphthoquinone treated lung cancer cells. Cancer Detect Prev 27, 5–13.
Sinha BK, Mimnaugh EG, Rajagopalan S, Myers CE (1989) Adriamycin activation and oxygen free radical formation in human breast tumor cells: Protective role of glutathione peroxidase in adriamycin resistance. Cancer Res 49, 3844–8.
Yagoda N, von Rechenberg M, Zaganjor E et al. (2007) RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447, 864–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Simamura, E., Shimada, H., Ishigaki, Y. et al. Bioreductive activation of quinone antitumor drugs by mitochondrial voltage-dependent anion channel 1. Anato Sci Int 83, 261–266 (2008). https://doi.org/10.1111/j.1447-073X.2008.00241.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1447-073X.2008.00241.x